1 / 88

Anaesthetic Implications and Management in Preeclampsia & Eclampsia

Anaesthetic Implications and Management in Preeclampsia & Eclampsia. Dr. Shilpa Agarwal Moderator: Dr. JP Sharma. University College of Medical Sciences & GTB Hospital, Delhi. www.anaesthesia.co.in. email: anaesthesia.co.in@gmail.com. Contents .

ouida
Download Presentation

Anaesthetic Implications and Management in Preeclampsia & Eclampsia

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Anaesthetic Implications and Management in Preeclampsia & Eclampsia Dr. Shilpa Agarwal Moderator: Dr. JP Sharma University College of Medical Sciences & GTB Hospital, Delhi www.anaesthesia.co.in email: anaesthesia.co.in@gmail.com

  2. Contents • Classification of hypertensive disorders of pregnancy • Diagnosis of preeclampsia • Risk factors • Obstetric and Anaesthetic management • Complications of preeclampsia • Diagnosis and risk factors of Eclampsia • Obstetric and Anaesthetic management in Eclampsia • Complications of Eclampsia

  3. Introduction • Hypertensive disorders complicate nearly 5-10% of all pregnancies • Deadly triad with infection and haemorrhage • In developed countries, 16% of maternal deaths due to hypertensive disorders • Preeclampsia – a multifactorial, multi-system hypertensive disorder of pregnancy ,is most dangerous • etiology remains unknown • evidence-based management

  4. History

  5. Classification • In 2000, National High Blood Pressure Education Program classified hypertensive disorders complicating pregnancy as: • Gestational hypertension • Preclampsia- eclampsia • chronic hypertension • chronic hypertension with superimposed preeclampsia

  6. Gestational Hypertension • Blood Pressure ≥ 140/90 on two or more occasions - in a previously normotensive patient - after 20 weeks gestation - without proteinuria - returning to normal 12 weeks after delivery • Almost half of these develop preeclampsia syndrome

  7. Chronic Hypertension • Blood Pressure ≥ 140/90 before 20 weeks of gestation Or • Persistence of hypertension beyond 12 weeks after delivery.

  8. Preeclampsia superimposed on Chronic Hypertension • New-onset proteinuria ≥ 300 mg/24 hours in hypertensive women but no proteinuria before 20 weeks’ gestation • A sudden increase in proteinuria or blood pressure or platelet count <1 lakh/mm3 in women with hypertension and proteinuria before 20 weeks’ gestation • More adverse outcome than preeclampsia alone

  9. Preeclampsia • New onset of hypertension & proteinuria in a previously normotensive woman • after 20 weeks of gestation • Returning to normal after 12 weeks of pregnancy. • Edema not a part of diagnosis now. • A retrospective diagnosis • Eclampsia : new onset of seizures or unexplained coma during pregnancy or postpartum period in patients with pre-existing preeclampsia and without pre-existing neurological disorder.

  10. PREECLAMPSIA

  11. Epidemiology • Preeclampsia complicates nearly 6% - 10% of all pregnancies. • maternal ICU admission • Leading cause of preterm delivery-NICU • Birth of LBW babies- economic, social and medical burden • Leading cause of maternal and fetal morbidity and mortality.

  12. Classification of Preeclampsia

  13. Risk Factors • Preconception - Partner related • Nulliparity • limited exposure to paternal sperms • Partner who fathered a preeclamptic pregnancy in another women -Non partner related • History of Preeclampsia in previous pregnancy • Advanced maternal age • Family history of Preeclampsia • History of placental abruptio, IUGR, fetal death • Non hispanic black race

  14. Risk factors contd.. -Maternaldisease related • Obesity, BMI>35 doubles the risk • Hypertension • Diabetes • Thrombotic vascular diseases -Behaviour- • Smoking : - preventive -Pregnancy associated- • Multiple gestation • Molar pregnancy

  15. ETIOPATHOGENESIS • Exact mechanism unknown, disease of theories. • ABNORMAL PLACENTATION • Stage1: failure of trophoblastic invasion into myometrium Penetrates only decidua superficial placentation  ↓placental perfusion • stage2 : endothelial damage systemic manifestations of Preeclampsia

  16. 1.Abnormal placentation

  17. 2. Inflammatory mediators ↓PGI2 ↑TXA2 Vasoconstriction Platelet aggregation ↑Vasopressor response ↑uterine activity

  18. 3. GENETIC Family history of pre eclampsia: genetic origin Mutations in Complement Regulatory Protein gene Genes assoc.: MTHFR, F5 leiden, AGT, HLA, NOS3, F2(prothrombin), ACE

  19. 4. IMMUNOLOGIC • Exposure to sperms of different partner • long term exposure to paternal antigen in sperms of same partner- protective • activated auto antibodies to angiotensin receptor-1 AA-AT1activate AT1 receptorsincreased sensitivity to angiotensins  hypertension

  20. 5.ANTIANGIOGENIC PROTIENS

  21. Markers of Preeclampsia • ↑ plasma Homocystiene • ↑ serum sFlt1(soluble fms-like tyosine kinase) • ↓serum and urinary Platelet Growth Factor • ↓ Vascular Endothelial Growth Factor

  22. Pathophysiology

  23. Respiratory • Airway is edematous; • ↓ internal diameter of trachea • Pharyngolaryngeal edema •  risk of pulmonary edema; 3% women with preeclampsia.

  24. CNS • CNS manifestations include: headache, visual disturbances, hyperexcitability, hyperreflexia, coma,seizures Cause: cerebral edema and hypoperfusion

  25. CVS • Vasospasm and exaggerated responses to catecholamines • Increased vascular permeability • ↓ Colloid Oncotic Pressure • hypertension • endorgan ischemia • Intravascular volume deficit

  26. Haemat ology • Hemoconcentration (pts with anemia may appear to have normal hematocrit) • Thombocytopaenia  most common • Platelet count correlates with disease severity and incidence of abruptio placentae • DIC due to activation of coagulation cascadeoverconsumption of coagulants and platelets spontaneous haemorrhage.

  27. Hepatic • HELLP syndrome • Periportalhaemorrhage • subcapsular bleeding • hepatic rupture: 32% maternal mortality

  28. Renal Decreased GFR - oliguria - renal failure - uric acid, creatinine is elevated Glomerulopathy - proteinuria

  29. Uteroplacental circulation • Uteroplacental insufficiency • Fetal complications: - hypoxia -IUGR -Prematurity -IUD -Placental abruptio

  30. Prediction of Preeclampsia No screening test is really helpful Various screening methods are: • Diastolic notch at 24weeks by dopplerultrasonography • Absence or reversal of end diastolic flow • Average mean arterial pressure ≥ 90 mmHg in second trimester • Angiotensin infusion test: angiotensin infusion required to raise the blood pressure >20 mm Hg from baseline • Roll over test: rise in blood pressure >20 mmHg from baseline on turning supine at 28-32 weeks gestation is positive.

  31. Prevention • Regular Antenatal checkup: rapid gain in weight rising blood pressure edema proteinuria/deranged liver or renal profile • Low dose Aspirin in High risk group: ↑PGs and↓TXA2 • Calcium supplementation: no effects unless women are calcium deficient • Antioxidants- Vitamin C and E • Nutritional supplementation: zinc, magnesium, fish oil, low salt diet

  32. Obstetric Management

  33. Obstetrics management 1. Maternal evaluation : Hemoglobin and hematocrit platelet count : decreased, if < 1 lakh coagulation profile LFTs : indicated in all patients KFTs : raised (S.urea creatinine is decresaed in Normal pregnancy) Urine Routine : proteinuria

  34. Obstetrics management contd.. 2. Fetal evaluation: • Daily fetal movement count • Ultrasound • Doppler ultrasound for fetal blood flow • Velocimetry

  35. Obs. Manag contd.. 3. Treatment of Acute Hypertension: • Goal: to prevent adverse maternal sequalae • Aim: to keep DBP below 100 mm Hg and to lower MAP not >15-25%

  36. Anti Hypertensive Drugs

  37. Anti Hypertensives contd.. Bed rest Avoid Diuretics, ACE inhibitors, ARBs Avoid uterotonics

  38. ObsManag contd.. 4. Seizure Prophylaxis • Routinely used in severe PE • Magnesium sulphate: most commonly used • Initiated with onset of labor till 24h postpsrtum • For caesarean, started 2hrs before the section till 12hrs postpartum

  39. Recommended regime for MgSO4 • Zuspan or sibai regime: 4-6 gm i.v over 15 min f/b infusion of 1-2 gm/hr • Pritchard regime: 4 gm i.v over 3-5min f/b 5 gm in each buttock with maintenance of 5 gm i.m in alternate buttock 4 hrly

  40. Side effects of MgSO4 • Maternal : flushing, perspiration, headache, muscle weakness, pulmonary edema • Neonatal: lethargy, hypotonia, respiratory depression

  41. Magnesium levels Monitoring • Normal Serum levels- 1.7- 2.4 mg/dl • Therapeutic range- 5- 9mg/dl • Patellar reflex lost- >12mg/dl • Respiratory depression- 15-20 mg/dl • Cardiac arrest- >25mg/dl

  42. Management of MgSO4 Toxicity • Stop infusion • Intravenous Calcium 10 ml 10% over 10 minutes • Endotracheal intubation in respiratory depression

  43. Anaesthetic implications during MgSO4 therapy • MgSO4 potentiate and prolong the action of both depolarizing non-depolarizing muscle relaxants • At higher doses Mg2+ rapidly crosses the placental barrier, has been found to significantly ↓ FHR variability • Should be given cautiously with Ca2+ as may antagonize the anticonvulsant effect of MgSO4 • Also be cautious in patients with renal impairment • May ↑ the possibility of hypotension during regional block

  44. Obs. Manag. Contd.. 5. Delivery • The only definitive treatment • Preeclamptic patients divided into 3 categories A- Preeclampsia features fully subside B- partial control, but BP maintains a steady high level C- persistently increasing BP to severe level or addition of other features

  45. Management: Gp A: can wait till spontaneous onset of labor don’t exceed Expected Date of Delivery Gp B: >37wk terminate w/o delay <37wk, expectant management at least till 34wks Gp C: terminate irrespective of POG, start seizure prophylaxis and steroids if<34wks

  46. Anaesthetic management

  47. Pre anaesthetic Evaluation 1.Airway 2. Haemodynamic monitoring : blood pressure, ECG, Pulse oxymetry 3. Fluid status: volume depleted patients higher risk of hypotension with induction of anaesthesia 4. BP control 5. Coagulation status

  48. Invasive Haemodynamic monitoring • Invasive central blood pressure monitoring not routinely indicated • Does not improve patient outcome • Indications: -oliguria patients -pulmonary edema -poorly controlled maternal blood pressure - massive hemorrhage -frequent arterial blood gas measurements • Poor correlation between central venous and pulmonary capillary wedge pressure

  49. Anesthetic Goals of Labor Analgesia in Preeclampsia • To establish & maintain hemodynamic stability (control hypertension & avoid hypotension) • To provide excellent labor analgesia • To prevent complications of preeclampsia • Pulmonary edema • Eclampsia • Intracerebralhaemorrhage • Renal failure • To be able to rapidly provide anesthesia for Caesarean Section

  50. Analgesia For Labor & delivery • Neuraxial analgesia: Lumbar Epidural- gradual onset of sympathetic blockade cardiovascular stability ↓ stress response maintains uteroplacental circulation avoids neonatal depression extended analgesia if cesarean required excellent post op analgesia

More Related